BioNTech
BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.
All edits
Edits on 15 Feb, 2024
Amy Sar
Edits on 15 Feb, 2024
Amy Sar
Edits on 18 Jan, 2024
Edits on 27 Dec, 2023
Amy Sar
Edits on 22 Nov, 2023
Edits on 6 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Wellfound ID
biontech
Edits on 21 Apr, 2023
Megan Gustafson
Infobox
Industry
' fill='white' fill-rule='nonzero'%3e%3cpath d='M52 12c-22.048 0-40 17.952-40 40 0 10.848 4.48 21.376 12.288 28.864 7.008 6.752 16.096 10.592 25.792 11.04.48.032.992.096 1.472.096H52c10.336 0 20.128-3.904 27.616-11.04C87.616 73.312 92 63.04 92 52c0-22.048-17.952-40-40-40zm26.912 65.056c-1.472-5.216-8.448-8.032-13.696-10.112l-1.792-.736C60 64.8 60 63.488 60 61.6c0-1.344.672-3.264 1.888-4.416 3.104-2.72 4.736-6.464 4.736-10.816 0-8.8-6.144-15.168-14.624-15.168-8.448 0-14.336 6.24-14.336 15.168 0 4.544 1.536 8.192 4.512 10.816 1.248 1.12 1.792 3.072 1.792 4.416 0 1.344 0 3.008-4.16 4.704-5.12 2.112-11.904 4.992-15.008 10.432C18.688 69.984 15.2 61.12 15.2 52c0-20.288 16.512-36.8 36.8-36.8 20.288 0 36.8 16.512 36.8 36.8 0 9.408-3.52 18.208-9.888 25.056z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Deactivated User
Infobox
Industry
Edits on 6 Apr, 2023
Katrina-Kay Pettitt
Edits on 5 Apr, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 17 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 26 Jan, 2023
Golden AI
Edits made to:
Infobox (+2/-1 properties)
Infobox
Latest Funding Type
Latest Funding Round Amount (USD)
455,600,000
Latest Funding Type
Golden AI
Infobox
Funding Rounds
0
Edits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 11 Sep, 2022
Katrina-Kay Pettitt
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Find more companies like BioNTech
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.